Hypertension, Dialysis and Clinical Nephrology - Kidney


Audiofiles:    RRI-2004 :  RPA-2004 :  ADC-2004 :  ASN-2003 :  ADC-2003  :  RPA-2003 


Chronic Inflammation and Renal Disease: Practical Aspects. Part Two of Two.

(ASN Board Review Course. San Francisco, CA; August, 2004)
How is survival in ESRD patients affected by LDL cholesterol, serum albumin and CRP level? Is IL-6 a better marker? What are roles of serum amyloid A and fibrinogen? Which markers should we measure? Does membrane biocompatibility affect inflammatory cytokines? Water quality? Covert infections such as thrombosed access or periodontal disease? To what extent can the inflammatory syndrome be treated? (more...)

Chronic Inflammation and Renal Disease: Practical Aspects. Part One of Two.

(ASN Board Review Course. San Francisco, CA; August, 2004)
How do you distinguish between malnutrition and inflammation? What are the clinical limitations of measures of nutrition? Does malnutrition per se lower serum albumin? What are variables that predict serum albumin in HD and PD patients? What can we learn about measures of muscle mass, fat free mass, and malnutrition / inflammation? What effect does inflammation have on EPO sensitivity? (Part Two next week). (more...)

Hypertension, Cardiovascular
Low carb diet beats low fat diet
Nondiabetic hyperglycemia a CV risk factor
Almost everyone in the US has HTN
Antibiotics do not work to prevent CVD
Monoxidine normalizes symp activity in ESRD
Intensive statins and CVD progression
Dialysis, CKD
PPAR and diabetic nephropathy
Intradialytic CRP rises up mortality risk
Tesio caths give good long-term results
Pamidronate in renal Tx and GFR
Does going to single-use lower death rate?
Low sodium dialysate ups thirst, lowers IDWG
Fluctuating CRP not a risk factor in ESRD
Clinical Nephrology
None this week

  Recent additions


(Article Free, $CE)
How Peritoneal Dialysis Works
Karen T. Kelley
Comparison of Peritoneal Dialysis Solutions
Terri L. Crawford-Bonadio and Jose A. Diaz-Buxo
Troubleshooting Non-Infectious Peritoneal Dialysis Issues
Donna E. Maaz

Now in MP3
Keynote Address
   - Cardiac Diseases in Kidney Disease Patients; Current Understanding and Opportunities for Change;
(A. Levin)  (more...)

Consensus Topics
   - Atherosclerosis in ESRD : Genesis of Atherosclerosis: Can it be identified and its progress slowed early in CKD?;
   - Atherosclerosis in ESRD : What is the practical approach to atherosclerosis in ESRD?;
   - Atherosclerosis in ESRD : Vascular Calcification: Mechanisms & Control;
   - Calcimimetics vs. Vitamin D: What are their relative roles?;
   - Volume Status in ESRD : Comparison between PD and HD; influence of peritoneal solutions;
   - Volume Status in ESRD : Blood pressure and volume control: treatment strategies; importance of water versus sodium removal;
   - Volume Status in ESRD : Dry weight; new developments;
   - Volume Status in ESRD : Importance of residual renal function; impact on volume status; pathophysiology of decline;
(Tsao, Ritz, Chen, Drueke, Lameire, Leunissen, Greenwood, Pecoits-Filho)  (more...)

    Hit reload / refresh
Updated: November 03, 2004 (N03)
N03 Fresenius Medical raises forecast on more patients
N03 Medicare Program published revisions to MD payment policies for 2005
N03 Research confirms that mad cow disease prions can be removed from blood
N03 Transmission of mad cow disease by transfusion leads to fears of a second wave
N01 Quest Diagnostics gets DOJ subpoena related to Nichols Lab PTH tests
N01 Rosiglitazone enhances fat cell energy metabolism
N01 Gut microbes linked to propensity to obesity
N01 ASN: Stable Hb levels with q4week dosing using CERA
N01 Genzyme calls for research proposals for grant program
O31 ASN: Coronary angiography or bypass underutilized in dialysis patients
O31 Complex cause for brittle bones
O31 Smart stethoscope hears stones break during lithotripsy
O30 The amyloidogenic role of apolipoprotein E in Alzheimer disease clarified
O30 ASN: Sevelamer reduces coronary calcification in new dialysis patients
O30 ASN: Riquent lowers dsDNA levels in lupus patients as adjuvant therapy
O30 ASN: Nocturnal hemodialysis results from Canada very encouraging
O30 ASN: Hectorol phase III results in CKD
O30 ASN: Fosrenol maintains bone health on longer term use
O29 Web kidney donor jailed for child support debt
O29 Bone Care International receives DOJ subpoena
General Advances Emphasis
Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome
Youfei Guan from Vanderbilt discusses new evidence linking PPAR receptors to the metabolic syndrome and to diabetic nephropathy. The utility of PPAR modulators in treating diabetic nephropathy and potentially, metabolic syndrome, is emphasized; in the November issue of J Am Soc Nephrol. (more...)

Diabetic nephropathy : Linking histology, cell biology, and genetics
Sharon Adler review the histology and pathophysiology, as well as genetics, of diabetic nephropathy, in the November issue of Kidney International. (more...)

Cardiovascular risk in chronic kidney disease
Nagesh Anavekar and Marc Pfeffer discuss the latest information on traditional and non-conventional risk factors in CKD, and why CV mortality is increased, in a November Supplement issue of Kidney International. (more...)

Management of lupus nephritis: An update
Frederic Houssiau from Bruxelles reviews the new randomized trial results in treatment of lupus, and what they tell us about use of glucocorticoids, cyclophosphamide, and mycophenolate mofetil. In the October issue of the J Am Soc Nephrol. (more...)

Pathophysiology of Pre-eclampsia
Davison from Newcastle upon Tyne and his colleagues from Germany and the USA get together to describe the new insights relating to pathogenesis, including relaxin, fms-like tyrosine kinase 1, asymmetric dimethylarginine, and novel autoantibodies that may activate angiotensin receptors. In the September issue of the J Am Soc Nephrol. (more...)

Changing face of childhood nephrotic syndrome
Russell Chesney discusses how causes as well as treatment of nephrotic syndrome in children have changed in the recent past; in the September issue of Kidney Int. (more...)

  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

Chronic Inflammation and Renal Disease: Practical Aspects. Part Two of Two.
Chronic Inflammation and Renal Disease: Practical Aspects. Part One of Two.
Herbs and Heavy Metals: A Recipe for Kidney Failure. Part Two. Heavy Metals.
Herbs and Heavy Metals: A Recipe for Kidney Failure. Part One. Herbs.
Bones, Moans, and Groans: Skeletal Disorders in Chronic Kidney Disease (CE $)
ABO Incompatible and Positive Crossmatch Renal Transplantation: A New Paradigm
Vein Mapping for Placement of Fistulas
Vascular Compliance: Impact on Cardiovascular and Renal Disease Risk
The Importance of Residual Renal Function and its Maintenance in Patients on Dialysis
Phosphorus-PTH-Bone: Achieving Balance and Avoiding Extraosseous Calcification (Three talks and discussion)
The Importance of Residual Renal Function and its Maintenance in Patients on Dialysis
Renal Challenges during Bone Marrow and Peripheral Blood Stem Cell Transplantation
Combined Pulmonary and Renal Impairment: Difficulties in Distinguishing Volume Contraction from Volume Overload
Antagonizing Vasopressin: AVP Receptor Antagonists
Long-Term Benefits of Pancreas Transplantation
  NephroAsia. Selected Talks (Lecture Notes) (Part 2 of 2)
  NephroAsia. Selected Talks (Lecture Notes) (Part 1 of 2)
How To Manage The Patient With Severe Hyperparathyroidism: The Role Of Newer Agents To Suppress Parathyroid Hormone Release
Medical and Surgical Approaches to Severe Hyperparathyroidism
Addressing Current Challenges and Clinical Implications in Iron Management (Three talks and discussion)
The Role of Parathyroidectomy: Medical Perspective
A Novel Approach to Controlling Secondary Hyperparathyroidism (HPT): Targeting the Calcium-Sensing Receptor (Three talks and discussion)
  Effective Business Approaches for Your Nephrology Practice (Part 2 of 2)
  Effective Business Approaches for Your Nephrology Practice (Part 1 of 2)
Uric Acid, the Kidney, and the Pathogenesis of Hypertension. Part Two of Two.
Uric Acid, the Kidney, and the Pathogenesis of Hypertension. Part One of Two.
Preserving Residual Renal Function in Diabetics After Initiating Dialysis
Evaluation and Management of the Hepatitis C Virus Infected Pretransplant Candidate
Post-transplant Diabetes Mellitus
Hemolytic Uremic Syndrome: Who Should Receive Plasma Exchange?
Vitamin D and the Prevention of Morbidity and Mortality in Dialysis Patients (Four talks and discussion)
SLE Nephritis in Different Clinical Populations: Therapeutic and Prognostic Considerations
Viral Diseases and Renal Transplantation (Four talks and discussion)
Therapy in Ischemic Nephropathy: A Data Based Approach
Morbidity & Mortality Across the CKD Continuum: Can A Renewed Focus on Anemia Improve Outcomes? (Four talks and discussion)
Role of Hepatitis C in the Immunopathogenesis of Glomerulonephritis and Cryoglobulinemia
HIV and Renal Transplantation
Mycophenolate Mofetil: Emerging Role in Glomerular Disease (Four talks and discussion)
Dialysis Dose in Acute Renal Failure: Measurement, Prescription, and Delivery
Chronic Kidney Disease: Emerging Strategies for Managing the Cardio-Renal Syndrome (Four talks and discussion)
Nutritional Assessment and Management: When and What to Prescribe
Making Sense: A Scientific Approach to IV Iron (Three talks and discussion)
Literature Review: A Year in Nephrology - Fluids and Electrolytes
Potassium: Key Physiologic Principles, Hypokalemic and Hyperkalemic Disorders. Part 2 of 2.
Potassium: Key Physiologic Principles, Hypokalemic and Hyperkalemic Disorders. Part 1 of 2.
Intravenous Iron Management for Pharmacists: Safety, Efficacy, Dosing and Pharmacoeconomic Considerations
Serologic Diagnosis of Glomerular Disease. Part Two of Two
Serologic Diagnosis of Glomerular Disease. Part One of Two
Anion Gap Metabolic Acidosis
Hypotension on Dialysis: Pathogenesis and Treatment. Part Two of Two
Hypotension on Dialysis: Pathogenesis and Treatment. Part One of Two
Addressing The Ongoing Clinical Debate: Implications of Iron Therapy
Issues of Volume Regulation. Case Discussions. Part Two of Two.
Issues of Volume Regulation. Case Discussions. Part One of Two.
Edema States, Pathophysiology and Therapy. Part Two of Two: Therapy.
Edema States, Pathophysiology and Therapy. Part One of Two: Pathophysiology
Regulation of Sodium Balance: A Summary of Practical Physiology
Renal Water Handling: A Summary of Practical Physiology
Best Nursing Practices for Central Venous Hemodialysis Catheters (Three talks)
Resistant Hypertension: Case Discussions. Part Two.
Resistant Hypertension: Case Discussions. Part One.
Focus on the Future: Realities, Challenges, Solutions
Can Pharmacologic Interventions Prevent or Treat Acute Renal Failure?
Options and Issues in Anemia Management (Four talks)
Assessment of Renal Function in Chronic Liver Disease
IV Iron: Patients & Professionals in Dialogue: Addressing Concerns of Hemodialysis Patients (Three talks)
Treatment of Focal Glomerulosclerosis (FSGS)
CPC: The Nephrotic Syndrome
Dialysis Trials in Acute Renal Failure: What Have We Learned?
Keeping Your Water Safe
New Treatment Approaches and Clinical Trials in Lupus Nephritis
Defining Acute Kidney Failure - The Acute Dialysis Quality Initiative (ADQI)
Hepatitis C Virus - Associated Kidney Diseases
Nutrition Across the Continuum of Care in Kidney Disease
Glomerulonephritis: the Deposition Diseases
Introduction to Laboratory Values
System Barriers to Creating the Best Angioaccess for Our Patients
Practical Management of Secondary Hyperparathyroidism: From Basic Science to Clinical Medicine (Three talks, discussion)
Clinical Strategies to Minimize Glucose Toxicities to the Peritoneal Membrane
Confronting Change in Nephrology Practice: Knowledge, Strategies, Tools
Adsorptive Techniques Applied to ESRD
Improving Outcomes in High-Risk Patients with Hypertension. (Four talks, debate, discussion)
Changes in Vascular Compliance in Chronic Renal Disease. Basic Principles (Part 1) and Clinical Implications (Part 2).
Bone Biopsy
Development of Hemodialysis: From Access to Machines
Nutritional Management of the Critically Ill Patient
Induction Therapy
Resistant Infection in Dialysis Patients
Avoiding Resistant Infection in Dialysis Patients
Current Iron Deficiency in CKD: Challenges/Controversies (Three talks, discussion)
Cannulation of Vascular Grafts and Fistulas
Are the New Immunosuppressants Improving Kidney Transplant Outcomes?
Executing Change in the Management of Chronic Kidney Disease (Four talks, discussion)

Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented in this journal/server.

Copyright statement:
Copyright - 1995 - 2004 by Medtext, Inc. All rights reserved. No part of the material on this journal/server may be reproduced in any form or by any electronic or mechanical means, including information storage and retrieval systems, without permission in writing from the publisher, except by a reviewer who may quote brief passages in a review.

Published by Medtext, Inc., Hinsdale, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com